Glimepiride
USP/1292303 - United States Pharmacopeia (USP) Reference Standard
Synonym: Glimepiride
CAS Number: 93479-97-1
Empirical Formula (Hill Notation): C24H34N4O5S
Molecular Weight: 490.62
MDL Number: MFCD00878417
Linear Formula: C24H34N4O5S
Product Type: Chemical
API family | glimepiride |
application(s) | pharmaceutical (small molecule) |
format | neat |
grade | pharmaceutical primary standard |
InChI | 1S/C24H34N4O5S/c1-4-21-17 |
InChI key | WIGIZIANZCJQQY-RUCARUNLSA |
manufacturer/tradename | USP |
SMILES string | CCC1=C(C)CN(C(=O)NCCc2ccc |
Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
Application: | Glimepiride is currently used to treat type 2 diabetes. |
Application: | Glimepiride USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as: • Glimepiride Tablets • Pioglitazone and Glimepiride Tablets |
Biochem/physiol Actions: | Glimepiride is a potent blocker of cardiac KATP channels activated by pinacidil with an IC50 of 6.8 nM. |
General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia . |
Other Notes: | Sales restrictions may apply. |
Symbol | GHS08 |
Signal word | Warning |
Hazard statements | H361 |
Precautionary statements | P201 - P202 - P280 - P308 + P313 - P405 - P501 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
UNSPSC | 41116107 |